Therapeutic expertise

Cardiology Clinical Trial Sites

WCR evaluates cardiovascular protocols through multi-specialty investigators, established patient populations, 12-lead ECG capability, and bilingual study support.

Program fit

Cardiovascular research connected to primary and metabolic care

Our network can evaluate protocols involving cardiovascular risk and related chronic conditions. Feasibility includes investigator alignment, target-patient access, procedural requirements, safety oversight, and visit burden.

  • Hypertension
  • Cardiovascular risk
  • Heart disease
  • Arrhythmia-related research
  • Dyslipidemia
  • Cardiometabolic conditions

Clinical support

  • 12-lead ECG machine
  • Blood-pressure equipment
  • Defibrillator and crash cart
  • Medical oxygen
  • Clinical sample processing

From our case studies

Cardiovascular research: the path to first screening

The team coordinated startup in two distinct stages. Site selection to activation took 28 days, followed by 15 days from activation to first screening. The full case explains what happened within that 43-day pathway.

28days: selection to activation
15days: activation to first screening
43days: selection to first screening
Read the full study story

For sponsors & CROs

Cardiovascular study readiness before the first screening

WCR supports cardiovascular research feasibility through investigator experience, clinical assessment resources and coordinated network operations. Existing expertise spans hypertension, cardiovascular risk, dyslipidemia and related cardiometabolic conditions. The cardiovascular startup case explains how budgets, regulatory requirements, staff access and candidate preparation progressed together before screening began.

From feasibility to study visits

  1. Review investigator fit, cardiovascular risk and protocol-specific clinical requirements.

  2. Coordinate ECG, blood-pressure assessments and clinical sample processing as required by the study.

  3. Advance operational startup and candidate preparation in parallel, with responsibilities visible to the team.

Relevant investigator experience

Clinical experience behind the feasibility review

Puerto Rico

Juan Carlos Rivera Arce, MD

Cardiology and internal-medicine experience spanning cardiovascular disease, arrhythmias and metabolic risk.

Puerto Rico

Gustavo R. Albizu-Angulo, MD

Research experience in obesity, diabetes, cardiovascular risk, inflammatory bowel disease, vaccines, asthma and migraine.

Miami Lakes, Florida

Lucky Flores, MD

Research experience across GI, dermatology, obesity, diabetes, respiratory disease, vaccines and women’s health.

Investigator assignment, location suitability and study-specific resources are confirmed during feasibility. Explore both research locations

For participants

Considering a cardiovascular study?

Participation is always voluntary. The study team explains eligibility, procedures, risks, possible benefits, and alternatives before consent.

View Enrolling Trials

Related expertise

Connected therapeutic areas

Evaluate a cardiology protocol